Moreover, genetic or pharmacological inhibition of Sema3E/PlexinD1 signaling has been shown to attenuate adipose inflammation, improve insulin sensitivity, and normalize glucose tolerance in obese mice, indicating that Sema3E is not only a marker of metabolic inflammation but is also a functional contributor to insulin resistance. The gene discussed is SEMA3E; the disease is Insulin resistance.